ATRECA INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ATRECA INC and buy or sell other stocks, ETFs, and their options commission-free!About BCEL
Atreca is a biopharmaceutical that develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. Its product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using its discovery platform.
CEOJohn A. Orwin, MBA
CEOJohn A. Orwin, MBA
Employees—
Employees—
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2010
Founded2010
Employees—
Employees—
BCEL Key Statistics
Market cap3.57M
Market cap3.57M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume49.90K
Average volume49.90K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.18
52 Week high$1.18
52 Week low$0.052
52 Week low$0.052